Cited by 627Mitochondrial Function and PathologyCell death mechanisms and regulationCardiac Ischemia and Reperfusion

The DOI matches its Crossref record; 276 of the 276 references it cites were found in a registry or an index.

The mitochondrial permeability transition from in vitro artifact to disease target

Abstract

The mitochondrial permeability transition pore is a high conductance channel whose opening leads to an increase of mitochondrial inner membrane permeability to solutes with molecular masses up to approximately 1500 Da. In this review we trace the rise of the permeability transition pore from the status of in vitro artifact to that of effector mechanism of cell death. We then cover recent results based on genetic inactivation of putative permeability transition pore components, and discuss their meaning for our understanding of pore structure. Finally, we discuss evidence indicating that the permeability transition pore plays a role in pathophysiology, with specific emphasis on in vivo models of disease.

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1742-4658.2006.05213.x

Cites

276 of 276 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Since these dysfunctions are known to activate mPTP, mPTP activity is expected to be enhanced in dysfunctional mitochondria in aging.

    “Since these dysfunctions are known to activate mPTP [2], it can be expected that mPTP activity will be enhanced in dysfunctional mitochondria in aging.”

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. Raaflaub J, 1953, Die schwellung isolierter leberzell mitochondrien und ihre physikalisch beeinfluβarkeit, Helv Physiol Pharmacol Acta, 11, 142
  2. Raaflaub J, 1953, Über den wirkungsmechanismus von adenosintriphosphat (ATP) als cofaktor isolierter mitochondrien, Helv Physiol Pharmacol Acta, 11, 157
  3. Brenner‐Holzach O, 1954, Die korrelation zwischen der schwellung isolierter mitochondrien und dem abbau intramitochondrialen adenosinnucleotide (ATP, ADP, AMP, CoA), Helv Physiol Pharmacol Acta, 12, 242
  4. 10.1042/0264-6021:3580147 · DOI · Paper page
  5. 10.1016/S0014-5793(01)03314-2 · DOI

Cited by

Sorted by citations

Metadata

Authors
Bernardi, P., Krauskopf, A., Basso, E., Petronilli, V., Blalchy‐Dyson, E., Di Lisa, F., & Forte, M. A.
Affiliations
  • University of Padua (IT)
  • Oregon Health & Science University (US)
Venue
The FEBS Journal
Publisher
Wiley
Published
2006-04-10
Volume
273
Issue
10
Pages
2077-2099
ISSN
  • 1742-464X (ISSN-L)
  • 1742-4658
OpenAlex
W2060605524
Cited by
627
References
276
Citations by year
2026: 4 · 2025: 13 · 2024: 11 · 2023: 20 · 2022: 19 · 2021: 23 · 2020: 23 · 2019: 26 · 2018: 28 · 2017: 20 · 2016: 23 · 2015: 24 · 2014: 38 · 2013: 39 · 2012: 37
FWCI
4.64
Type
journal article
Language
en
Open access
closed
Locations
  • FEBS Journal (publishedVersion)
  • PubMed (publishedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Funders
  • National Institutes of Health
  • National Institute of General Medical Sciences (R01GM069883, GM 69883)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
Keywords
mitochondrial permeability transition pore, inner mitochondrial membrane permeability, cell death, gene inactivation, pore structure, mitochondrial disease, in vivo disease models
MeSH terms
Mitochondrial Permeability Transition Pore, Animals, Humans, Liver Diseases, Muscular Diseases, Nervous System Diseases, Artifacts, Drug Delivery Systems, Myocardial Ischemia, Mitochondrial Membrane Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review